Ingevity (NYSE:NGVT) reported Q1 EPS of $1.62, $0.58 better than the analyst estimate of $1.04. Revenue for the quarter came in at $382.8 million versus the consensus estimate of $341.58 million.
GUIDANCE:
Ingevity sees FY2022 revenue of $1.525-1.65 billion, versus the consensus of $1.54 billion.